Guidelines for the diagnosis and management of nonalcoholic fatty liver disease: Update 2010: (Published in Chinese on Chinese Journal of Hepatology 2010; 18:163-166) JG Fan etal. Diagnosis and management of NAFLD

Journal of Digestive Diseases

Volumn 12, Issue 1, 2011, Pages 38-44

  Fan, Jian Gao ^a   Jia, Ji Dong ^c   Li, You Ming ^d   Wang, Bing Yuan ^f   Lu, Lun Gen ^b   Shi, Jun Pin ^e   Chan, Lik Yuen ^g  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e Hangzhou 6th People's Hospital   (China)

^f CHINA MEDICAL UNIVERSITY   (China)

^g CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AMINOTRANSFERASE; GLYCYRRHIZIC ACID; METFORMIN; PIOGLITAZONE; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SIBUTRAMINE; SILYMARIN; TETRAHYDROLIPSTATIN; URSODEOXYCHOLIC ACID;

AEROBIC EXERCISE; ARTICLE; BARIATRIC SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DYSLIPIDEMIA; ECHOGRAPHY; HEALTH EDUCATION; HISTOLOGY; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID DIET; LIVER CIRRHOSIS; MEDICAL DECISION MAKING; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PATHOLOGY; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEDENTARY LIFESTYLE; TRADITIONAL MEDICINE;

ASIAN CONTINENTAL ANCESTRY GROUP; FATTY LIVER; HUMANS;

EID: 79251581867     PISSN: 17512972     EISSN: 17512980     Source Type: Journal    
DOI: 10.1111/j.1751-2980.2010.00476.x     Document Type: Article

References (29)

1. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (Suppl 1): S99-112.
2. Alwis NM de, Day CP. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008; 48 (Suppl 1): S104-112.
3. Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 2009; 50: 204-10.
4. Farrell GC, Chitturi S, Lau GK, Sollano JD, Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of non-alcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007; 22: 775-7.
5. American Gastroenterological Association. American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1702-4.
6. Grattagliano I, Portincasa P, Palmieri VO, Palasciano G. Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician 2007; 53: 857-63.
7. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-28.
8. Cohen DE, Anania FA, Chalasani N, Lipid N. Association Statin Safety Task Force Liver Expert Panel. An assessment of statin safety by hepatologists. Am J Cardiol 2006; 97: 77C-81C.
9. Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 2009; 49: 306-17.
10. Zeng MD, Fan JG, Lu LG etal. Chinese National Consensus Workshop on Nonalcoholic Fatty Liver Disease. Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases. J Dig Dis 2008; 9: 108-12.
11. Lok AS, McMahon BJ, Practice Guidelines Committee, American Association for the Study of Liver Diseases (AASLD). Chronic hepatitis B: update of recommendations. Hepatology 2004; 39: 857-61.
12. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment Pharmacol Ther 2007; 25: 883-9.
13. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia-Pacific Working Party for NAFLD. What are the risk factors and settings of non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol 2007; 22: 794-800.
14. Cheung O, Sanyal AJ. Hepatitis C infection and nonalcoholic fatty liver disease. Clin Liver Dis 2008; 12: 573-85.
15. Fan JG, Chitturi S. Hepatitis B and fatty liver: causal or coincidental? J Gastroenterol Hepatol 2008; 23: 679-81.
16. Fan JG. Strengthen the management of chronic viral hepatitis patients with fatty liver. Zhonghua Ganzangbing Zazhi 2009; 17: 801-3 (in Chinese).
17. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008; 134: 1682-98.
18. Fan JG. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications. J Dig Dis 2008; 9: 63-7.
19. Bugianesi E. Nonalcoholic fatty liver disease (NAFLD) and cardiac lipotoxicity: Another piece of the puzzle. Hepatology 2008; 47: 2-4.
20. Kleiner DE, Brunt EM, Van Natta M etal. Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005; 41: 1313-21.
21. Loomba R, Sirlin CB, Schwimmer JB, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Hepatology 2009; 50: 1282-93.
22. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat Dis Int 2007; 6: 572-8.
23. Ali R, Cusi K. New diagnostic and treatment approaches in non-alcoholic fatty liver disease (NAFLD). Ann Med 2009; 41: 265-78.
24. Fan JG. Relationship between diabetes and liver disease and strategy for its diagnosis and treatment. Zhonghua Tangniaobing Zazhi 2009; 1: 244-7 (in Chinese).
25. Fan JG, GC F, Asia-Pacific working party for prevention of hepatocellular carcinoma. Prevention of hepatocellular carcinoma in non-viral related liver diseases. J Gastroenterol Hepatol 2009; 24: 712-9.
26. Bellentani S, Dalle Grave R, Suppini A, Marchesini G, Fatty Liver Italian Network. Behavior therapy for nonalcoholic fatty liver disease: the need for a multidisciplinary approach. Hepatology 2008; 47: 746-54.
27. Hainer V, Toplak H, Mitrakou A. Treatment modalities of obesity: what fits whom? Diabetes Care 2008; 31 (Suppl 2): S269-277.
28. Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr 2007; 86: 285-300.
29. Riley P, Al Bakir M, O'Donohue J, Crook M. Prescribing statins to patients with nonalcoholic fatty liver disease: real cardiovascular benefits outweigh theoretical hepatotoxic risk. Cardiovasc Ther 2009; 27: 216-20.